CLOV vs NAMSW · rev $1.37B vs rev $45.6M
Clover Health Investments Corp (CLOV) versus NewAmsterdam Pharma Company N.V. Warrant (NAMSW) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) common stock listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NAMSW revenue for 2024-12-31 was $45.6M. Net income was -$241.6M. Revenue was up 223.4% from 2023-12-31 to 2024-12-31. NAMSW currently screens at market cap $0.
CLOV currently screens at market cap $1.55B. NAMSW currently screens at market cap $0.
Not investment advice. Open the CLOV and NAMSW stock pages for the full models.
Not investment advice.